In summary, we showed that pretreatment of human prostate cancer cells with cisplatin or LA-12 resulted in significant potentiation of TRAIL-induced cell death via engagement of mitochondrial apoptotic pathway, associated with pronounced Bid cleavage, Bak activation, loss of MMP and caspase activation. This evidence concerns the gene TNFSF10 and Familial prostate cancer.